BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5570167)

  • 1. Experimental investigation of immunreactivity against Candida albicans. 1. Reaction of rabbits immunized with Candida albicans and challenged with living Candida albicans.
    Balogh E; Kakuk G; Halmy K; Szabolcsi M
    Mykosen; 1971 Aug; 14(8):385-92. PubMed ID: 5570167
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental investigation of immunreactivity against Candida albicans. 2. The effect of azathioprin (Imuran) on immunreactivity against Candida albicans.
    Kakuk G; Balogh E; Szabolcsi M; Halmy K
    Mykosen; 1972 Feb; 15(2):73-82. PubMed ID: 4553263
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of anti-lymphocytic serum on experimental infection with Candida albicans in guinea pigs.
    Grubek H; Szymańska D; Trenkner E; Weyman-Rzucidlo D; Okoń M
    Acta Microbiol Pol A; 1970; 2(1):21-30. PubMed ID: 4987715
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis.
    Zhang H; Chen H; Niu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2653-9. PubMed ID: 19218608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the specifity of the demonstration of complement-fixing antibodies in blostomycoses].
    Friedrich E
    Z Immunitatsforsch Allerg Klin Immunol; 1966 May; 130(4):373-9. PubMed ID: 4231169
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological and pathological observations with Candida albicans-infected animals.
    Kuttin ES; Müller J; Douchet C; Vogt A
    Sabouraudia; 1983 Sep; 21(3):185-94. PubMed ID: 6356407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte stimulation in Candida albicans infections.
    Frisk A; von Stedingk LV; Wasserman J
    Sabouraudia; 1974 Mar; 12(1):87-94. PubMed ID: 4210102
    [No Abstract]   [Full Text] [Related]  

  • 8. Responses of thymectomized and-or bursectomized chickens to sensitization with Candida albicans.
    Fujiwara A; Landau JW; Newcomer VD
    Sabouraudia; 1970 May; 8(1):9-17. PubMed ID: 5427156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the agglutination titre against Candida albicans in serum of healthy persons].
    Kapell J
    Z Arztl Fortbild (Jena); 1970 Sep; 64(18):943-5. PubMed ID: 5486169
    [No Abstract]   [Full Text] [Related]  

  • 10. [Orientational studies for the demonstration of various antibodies against fungi in animal and human serums. II. The occurrence of IgM and IgG antibodies against C. albicans in human and rabbit serums].
    Tomsíková A; Seeliger HP
    Mykosen; 1969 Mar; 12(3):195-202. PubMed ID: 5407932
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of antibody responses to cell wall mannan and a major cytoplasmic antigen of Candida albicans in rabbits and humans.
    Jones JM
    J Lab Clin Med; 1980 Nov; 96(5):845-60. PubMed ID: 6999104
    [No Abstract]   [Full Text] [Related]  

  • 12. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of salivary antibodies to inhibit Candida albicans adherence to human epithelial cells by tonsillar immunization in rabbits.
    Fukuizumi T; Nagamatsu H; Kojo T; Inoue H
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):398-404. PubMed ID: 16872376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Candida factors in serum and their inhibitors. II. Identification of a Candida-clumping factor and the influence of the immune response on the morphology of Candida and on anti-Candida activity of serum in rabbits.
    Smith JK; Louria DB
    J Infect Dis; 1972 Feb; 125(2):115-22. PubMed ID: 4550226
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between fluorescent, agglutinating, and precipitating antibodies to Candida albicans and their immunoglobulin classes.
    Lehner T; Buckley HR; Murray IG
    J Clin Pathol; 1972 Apr; 25(4):344-8. PubMed ID: 4555044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.
    Standaert-Vitse A; Jouault T; Vandewalle P; Mille C; Seddik M; Sendid B; Mallet JM; Colombel JF; Poulain D
    Gastroenterology; 2006 May; 130(6):1764-75. PubMed ID: 16697740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic reaction induced by Candida albicans (1. continuation)].
    Seeliger HP; Tomsikova A; Török I
    Mykosen; 1975 Mar; 18(3):119-34 contd. PubMed ID: 1094282
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid identification of yeasts of the Candida albicans and Candida tropicalis specific by slide agglutination with species serum.
    Sefer M; Verenca C; Sobescianschi C
    Rom Med Rev; 1971; 15(1):8-10. PubMed ID: 5565322
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.
    Sendid B; Dotan N; Nseir S; Savaux C; Vandewalle P; Standaert A; Zerimech F; Guery BP; Dukler A; Colombel JF; Poulain D
    Clin Vaccine Immunol; 2008 Dec; 15(12):1868-77. PubMed ID: 18971303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.